- Home
- GTLS vs MEDP Comparison
GTLS vs MEDP Comparison
Compare GTLS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTLS
- MEDP
- Stock Information
- Founded
- GTLS 1859
- MEDP 1992
- Country
- GTLS United States
- MEDP United States
- Employees
- GTLS N/A
- MEDP N/A
- Industry
- GTLS Metal Fabrications
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- GTLS Industrials
- MEDP Health Care
- Exchange
- GTLS Nasdaq
- MEDP Nasdaq
- Market Cap
- GTLS 9.2B
- MEDP 10.5B
- IPO Year
- GTLS 1992
- MEDP 2016
- Fundamental
- Price
- GTLS $181.75
- MEDP $340.22
- Analyst Decision
- GTLS Strong Buy
- MEDP Buy
- Analyst Count
- GTLS 13
- MEDP 10
- Target Price
- GTLS $189.62
- MEDP $389.89
- AVG Volume (30 Days)
- GTLS 600.2K
- MEDP 317.8K
- Earning Date
- GTLS 02-28-2025
- MEDP 02-10-2025
- Dividend Yield
- GTLS N/A
- MEDP N/A
- EPS Growth
- GTLS N/A
- MEDP 42.23
- EPS
- GTLS 3.20
- MEDP 12.63
- Revenue
- GTLS $4,068,500,000.00
- MEDP $2,109,054,000.00
- Revenue This Year
- GTLS $28.59
- MEDP $7.54
- Revenue Next Year
- GTLS $10.95
- MEDP $11.55
- P/E Ratio
- GTLS $56.50
- MEDP $26.94
- Revenue Growth
- GTLS 46.41
- MEDP 11.84
- 52 Week Low
- GTLS $101.60
- MEDP $302.01
- 52 Week High
- GTLS $220.03
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- GTLS 34.49
- MEDP 47.17
- Support Level
- GTLS $186.98
- MEDP $336.78
- Resistance Level
- GTLS $198.75
- MEDP $347.58
- Average True Range (ATR)
- GTLS 8.32
- MEDP 12.05
- MACD
- GTLS -2.41
- MEDP -0.79
- Stochastic Oscillator
- GTLS 7.15
- MEDP 34.48
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.